Marcus Zachary, Park Nanah Suk
Pediatr Ann. 2017 Feb 1;46(2):e34-e39. doi: 10.3928/19382359-20170124-01.
Most children in the United States with intermittent, mild, and moderate persistent asthma are cared for by primary care practitioners (PCPs). Despite inhaled corticosteroids (ICS) being highly effective at controlling asthma symptoms, many PCPs are uncomfortable prescribing these medications. Cumbersome guidelines, increasing numbers of medication choices, and concerns regarding side effects are some of the barriers to prescribing ICS for children with asthma. This article serves as a quick-start guide for PCPs that (1) condenses the routine diagnosis and management of asthma into concise clinical tools for children who would benefit from ICS therapy and (2) provides clinical pearls to aid in the treatment of mild- to moderate-persistent asthma. [Pediatr Ann. 2017;46(2):e34-e39.].
美国大多数患有间歇性、轻度和中度持续性哮喘的儿童由初级保健医生（PCP）负责照料。尽管吸入性糖皮质激素（ICS）在控制哮喘症状方面非常有效，但许多初级保健医生对开具这些药物并不放心。繁琐的指南、越来越多的药物选择以及对副作用的担忧是为哮喘儿童开具ICS的一些障碍。本文为初级保健医生提供了一份快速入门指南，（1）将哮喘的常规诊断和管理浓缩为适用于可从ICS治疗中获益儿童的简明临床工具，（2）提供临床要点以辅助治疗轻度至中度持续性哮喘。[《儿科年鉴》。2017年；46(2):e34 - e39。]
